Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Tech · Laboratory Analytical Instruments

MKS Instruments Inc to acquire Coherent Inc

Announced Feb 8, 2021 · Terminated Feb 12, 2021

Deal value$6.00BEV $6.88B
Premium16.0%To unaffected price
EV / Adj. EBITDA—5.6x EV / Revenue
ConsiderationCash and stock$281.21 per share

Transaction

Acquirer
MKS Instruments Inc (MKSI)
Target
Coherent Inc
Buyer type
Strategic
Offer price per share
$281.21
Enterprise value
$6.88B
Status
Terminated Feb 12, 2021

Deal protections

Break fee (target pays)
$109M · 1.8%
Reverse fee (buyer pays)
$500M · 8.3%
Go-shop
No-shop
Financing
Committed · JPMorgan, Citigroup, MUFG, HSBC, Mizuho, BMO Capital Markets

Advisors

To the acquirer
Not disclosed
To the target
BofA Securities

Sector context · Tech

Comparable deals
19 in the prior 24 months
Premium
16.0% vs. 34.1% sector median
EV / Adj. EBITDA
Sector median 17.3x
Break fee
1.8% vs. 2.9% sector median

Timeline

  1. AnnouncedFeb 8, 2021
  2. TerminatedFeb 12, 2021
Sources
  • 425 · Feb 8, 2021

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.